Anuh Pharma Ltd (ANUHPHR) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 905552, "name": "Anuh Pharma", "stock_name": "Anuh Pharma", "full_name": "Anuh Pharma Ltd", "name_url": "stocks-analysis/anuh-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "75.00", "chg": 0.46, "chgp": "0.62%", "dir": 1, "prev_price": "74.54", "mcapval": "759.00 Cr", "mcap": "Micro Cap", "scripcode": 506260, "symbol": "ANUHPHR", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE489G01022", "curr_date": "Mar 20", "curr_time": "", "bse_nse_vol": "29.34 k", "exc_status": "Active", "traded_date": "Mar 20, 2026", "traded_date_str": "2026 03 20", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anuh-pharma-905552-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3902304", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_technicaldot_3902304.png", "date": "2026-03-20 08:03:08", "description": "Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend. Despite a recent downgrade in its Mojo Grade to Sell from Strong Sell, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others reinforce bearish pressures." }, { "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-bearish-signals-3895707", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_technicaldot_3895707.png", "date": "2026-03-17 08:03:11", "description": "Anuh Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Recent technical indicators, including MACD, RSI, and moving averages, signal increasing downside pressure, reflecting the stock’s underperformance relative to benchmarks such as the Sensex." }, { "title": "Anuh Pharma Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/anuh-pharma-ltd-is-rated-sell-by-marketsmojo-3882589", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_mojoScore_3882589.png", "date": "2026-03-10 10:10:18", "description": "Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3875212", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_technicaldot_3875212.png", "date": "2026-03-06 08:02:17", "description": "Anuh Pharma Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a nuanced change in investor sentiment. Despite a recent day gain of 2.54%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, underscoring the need for cautious analysis in the Pharmaceuticals & Biotechnology sector." }, { "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-bearish-signals-3863550", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AnuhPharmaLtd_technicaldot_3863550.png", "date": "2026-03-02 08:02:02", "description": "Anuh Pharma Ltd (Stock ID: 905552) has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape remains cautious, with key metrics such as moving averages and monthly MACD signalling downward pressure. This article analyses the recent technical parameter changes, price momentum, and how these signals align with the broader market context." }, { "title": "Anuh Pharma Gains 3.02%: 3 Key Factors Driving the Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-gains-302-3-key-factors-driving-the-weeks-mixed-momentum-3862417", "imagepath": "", "date": "2026-02-28 14:02:26", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Technical momentum shifts amid bearish signals</p>\n <p><strong>24 Feb:</strong> Valuation metrics improve, signalling enhanced price attractiveness</p>\n <p><strong>27 Feb:</strong> Technical momentum shifts again amid mixed market signals</p>\n <p><strong>Week Close:</strong> Rs.77.38 (+3.02%) vs Sensex (-0.96%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.75.11</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." }, { "title": "Anuh Pharma Ltd is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/anuh-pharma-ltd-is-rated-sell-by-marketsmojo-3860044", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AnuhPharmaLtd_mojoScore_3860044.png", "date": "2026-02-27 10:10:17", "description": "Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 February 2026, providing investors with the most recent insights into the company’s performance and outlook." }, { "title": "Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3859543", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AnuhPharmaLtd_technicaldot_3859543.png", "date": "2026-02-27 08:02:05", "description": "Anuh Pharma Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 3.73%, the company’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others remain subdued. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors." }, { "title": "Anuh Pharma Ltd Valuation Shifts Signal Improved Price Attractiveness Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/anuh-pharma-ltd-valuation-shifts-signal-improved-price-attractiveness-amid-mixed-market-returns-3852027", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AnuhPharmaLtd_valuationdot_3852027.png", "date": "2026-02-24 08:02:23", "description": "Anuh Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by a decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This revaluation comes amid a mixed performance backdrop in the Pharmaceuticals & Biotechnology sector, where peer comparisons and historical benchmarks provide a nuanced perspective on the stock’s price attractiveness and investment potential." } ], "total": 5142, "sid": "905552", "stock_news_url": "https://www.marketsmojo.com/news/anuh-pharma-905552" }, "announcements": [ { "caption": "Announcement Under Regulation 30 (LODR) - Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And Our Facilities Were Found Compliant Under The Audit.", "datetime": "06-Mar-2026", "details": "Completion of European Directorate for the Quality of Medicines & Healthcare (EDQM) Audit and our facilities were found compliant under the Audit", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "18-Feb-2026", "details": "Newspaper Publication regarding notice to shareholders for Special Window for transfer and dematerialisation (demat) of physical shares in reference to SEBI Circular dated January 30 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "13-Feb-2026", "details": "Investor Presentation for Q3 FY 2025-26", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Anuh Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 14 Aug 25", "dt": "2025-08-14", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Anuh Pharma Ltd has announced <strong>5:10</strong> stock split, ex-date: 31 Jul 06", "dt": "2006-07-31", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Anuh Pharma Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 15 Jul 25", "dt": "2025-07-15", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Feb: Technical momentum shifts amid bearish signals

24 Feb: Valuation metrics improve, signalling enhanced price attractiveness

27 Feb: Technical momentum shifts again amid mixed market signals

Week Close: Rs.77.38 (+3.02%) vs Sensex (-0.96%)

Read full news article

Anuh Pharma Ltd is Rated Sell by MarketsMOJO

2026-02-27 10:10:17

Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 February 2026, providing investors with the most recent insights into the company’s performance and outlook.

Read full news article

Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-27 08:02:05

Anuh Pharma Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 3.73%, the company’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others remain subdued. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors.

Read full news article

Anuh Pharma Ltd Valuation Shifts Signal Improved Price Attractiveness Amid Mixed Market Returns

2026-02-24 08:02:23

Anuh Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by a decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This revaluation comes amid a mixed performance backdrop in the Pharmaceuticals & Biotechnology sector, where peer comparisons and historical benchmarks provide a nuanced perspective on the stock’s price attractiveness and investment potential.

Read full news article